Ouça e se atualize sobre o novo Coronavírus com o TdC! O episódio foi dividido em duas partes, essa discute o manejo do paciente com suspeita de COVID-19.

MINUTAGEM

Abordagem dos Casos Suspeitos - Parte 1 [01:15].

Apresentação do Episódio [04:00].

Definição de Caso Suspeito [09:25].

Quadro Clínico [13:00].

Atendimento inicial ao Caso Suspeito [15:00].    

Tipos de máscaras [19:30].      

Alterações Laboratoriais e de Imagem [21:30].    

Estratificação e Manejo pela OMS [27:00].    

Medicamentos em estudo atualmente [32:00].    

Vacina [34:40]. 

REFERÊNCIAS:

1. NI, Yue-Nan et al. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Critical Care, v. 23, n. 1, p. 99, 2019.

2. RUSSELL, Clark D.; MILLAR, Jonathan E.; BAILLIE, J. Kenneth. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet, v. 395, n. 10223, p. 473-475, 2020. FANG, Lei;

3. KARAKIULAKIS, George; ROTH, Michael. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet Respiratory Medicine, 2020.

4. LIU, Weiyong et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. New England Journal of Medicine, 2020.

5. Sociedade internacional de ultrassom em GO ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020 Mar 11. doi: 10.1002/uog.22013.

6. FAVRE, Guillaume et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. The Lancet Infectious Diseases, 2020.

7. CHEN, Huijun et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 2020.

8. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Mar 13. pii: 138003. doi: 10.1172/JCI138003.

9. Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak Interim guidance 29 January 2020 - World Health Organization.

10. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance V 1.2.

11. “Field Briefing: Diamond Princess COVID-19 Cases, 20 Feb Update” Acessado em: https://www.niid.go.jp/niid/en/2019-ncov-e/9407-covid-dp-fe-01.html. 12. https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html

12. https://saude.rs.gov.br/upload/arquivos/202002/12090034-coronavirus-isolamento-domiciliar-1.pdf.

13. Markel, Howard, et al. "Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic." Jama 298.6 (2007): 644-654.

14. Wang, Wenling, et al. "Detection of SARS-CoV-2 in Different Types of Clinical Specimens." JAMA (2020).

15. Lai, Shengjie, et al. "Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak: an observational and modelling study." medRxiv (2020).

16. YAN, Gabriel et al. Covert COVID-19 and false-positive dengue serology in Singapore. The Lancet Infectious Diseases, 2020.

17. WANG, Dawei et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 2020.

18. ZHOU, Fei et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020.